APP and Alzheimer disease: For example, the classic formula Shen-Zhi-Ling Oral Liquid, which is used for the treatment of AD, can reduce APP mRNA expression in the hippocampus, reduce amyloid deposition, reduce Caspase-3 expression, reduce neuronal apoptosis [44, 45], and increase hippocampal haemoglobin.